667 related articles for article (PubMed ID: 27777118)
1. The occurrence of infective endocarditis with Staphylococcus lugdunensis bacteremia: A retrospective cohort study and systematic review.
Non LR; Santos CA
J Infect; 2017 Feb; 74(2):179-186. PubMed ID: 27777118
[TBL] [Abstract][Full Text] [Related]
2. Unusually virulent coagulase-negative Staphylococcus lugdunensis is frequently associated with infective endocarditis: a Waikato series of patients.
Liang M; Mansell C; Wade C; Fisher R; Devlin G
N Z Med J; 2012 May; 125(1354):51-9. PubMed ID: 22595924
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and outcomes in adult patients with Staphylococcus lugdunensis bacteremia compared to patients with Staphylococcus epidermidis and Staphylococcus aureus bacteremia: a retrospective study in a 16-year period at the university hospital, Japan.
Yukawa S; Noguchi T; Shinohara K; Tsuchido Y; Yamamoto M; Matsumura Y; Nagao M
BMC Infect Dis; 2023 May; 23(1):269. PubMed ID: 37127589
[TBL] [Abstract][Full Text] [Related]
4. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature.
Zinkernagel AS; Zinkernagel MS; Elzi MV; Genoni M; Gubler J; Zbinden R; Mueller NJ
Infection; 2008 Aug; 36(4):314-21. PubMed ID: 18648747
[TBL] [Abstract][Full Text] [Related]
5. Frequency, clinical manifestations, and outcomes of Staphylococcus lugdunensis Bacteremia in children.
Sato M; Kubota N; Horiuchi A; Kasai M; Minami K; Matsui H
J Infect Chemother; 2016 May; 22(5):298-302. PubMed ID: 26898664
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan.
Lin JF; Cheng CW; Kuo AJ; Liu TP; Yang CC; Huang CT; Lee MH; Lu JJ
J Microbiol Immunol Infect; 2015 Aug; 48(4):406-12. PubMed ID: 24529852
[TBL] [Abstract][Full Text] [Related]
7. Staphylococcus lugdunensis: a rare but destructive cause of coagulase-negative staphylococcus infective endocarditis.
Sabe MA; Shrestha NK; Gordon S; Menon V
Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):275-80. PubMed ID: 24523355
[TBL] [Abstract][Full Text] [Related]
8. Staphylococcus lugdunensis endocarditis with isolated tricuspid valve involvement.
Chung KP; Chang HT; Liao CH; Chu FY; Hsueh PR
J Microbiol Immunol Infect; 2012 Jun; 45(3):248-50. PubMed ID: 22041168
[TBL] [Abstract][Full Text] [Related]
9. Multicenter retrospective cohort study of the clinical significance of Staphylococcus lugdunensis isolated from a single blood culture set.
Hauser N; Kim JJ; Luethy PM; Schmalzle SA; Bork JT
Diagn Microbiol Infect Dis; 2021 Mar; 99(3):115261. PubMed ID: 33290922
[TBL] [Abstract][Full Text] [Related]
10. Infectious diseases specialist consultation in Staphylococcus lugdunensis bacteremia.
Forsblom E; Högnäs E; Syrjänen J; Järvinen A
PLoS One; 2021; 16(10):e0258511. PubMed ID: 34637480
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles.
Anguera I; Del Río A; Miró JM; Matínez-Lacasa X; Marco F; Gumá JR; Quaglio G; Claramonte X; Moreno A; Mestres CA; Mauri E; Azqueta M; Benito N; García-de la María C; Almela M; Jiménez-Expósito MJ; Sued O; De Lazzari E; Gatell JM;
Heart; 2005 Feb; 91(2):e10. PubMed ID: 15657200
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors.
Liu PY; Huang YF; Tang CW; Chen YY; Hsieh KS; Ger LP; Chen YS; Liu YC
J Microbiol Immunol Infect; 2010 Dec; 43(6):478-84. PubMed ID: 21195974
[TBL] [Abstract][Full Text] [Related]
13. Multicenter Study of the Clinical Presentation of Staphylococcus lugdunensis Bacteremia in Japan.
Ainoda Y; Takeshita N; Hase R; Mikawa T; Hosokawa N; Kawamura I; Kurai H; Abe M; Kimura M; Araoka H; Fujita T; Totsuka K; Mezaki K; Sekiya N; Ohmagari N
Jpn J Infect Dis; 2017 Jul; 70(4):405-407. PubMed ID: 28003590
[TBL] [Abstract][Full Text] [Related]
14. Endocarditis due to Staphylococcus lugdunensis-a retrospective national registry-based study.
Aldman MH; Rasmussen M; Olaison L; Påhlman LI
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):1103-1106. PubMed ID: 33378000
[TBL] [Abstract][Full Text] [Related]
15. Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.
Ruggero MA; Peaper DR; Topal JE
Infect Dis (Lond); 2015 Jun; 47(6):379-84. PubMed ID: 25746601
[TBL] [Abstract][Full Text] [Related]
16. Staphylococcus lugdunensis endocarditis--the hidden peril of coagulase-negative staphylococcus in blood cultures.
Seenivasan MH; Yu VL
Eur J Clin Microbiol Infect Dis; 2003 Aug; 22(8):489-91. PubMed ID: 12845551
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus lugdunensis endocarditis in children.
Guillaume MP; Dubos F; Godart F
Cardiol Young; 2017 May; 27(4):784-787. PubMed ID: 27748222
[TBL] [Abstract][Full Text] [Related]
18. Rifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study.
Shrestha NK; Shah SY; Wang H; Hussain ST; Pettersson GB; Nowacki AS; Gordon SM
Ann Thorac Surg; 2016 Jun; 101(6):2243-50. PubMed ID: 26872729
[TBL] [Abstract][Full Text] [Related]
19. Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia.
Choi SH; Chung JW; Lee EJ; Kim TH; Lee MS; Kang JM; Song EH; Jun JB; Kim MN; Kim YS; Woo JH; Choi SH
J Clin Microbiol; 2010 Sep; 48(9):3346-9. PubMed ID: 20592152
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus lugdunensis bacteremia and endocarditis treated with cefazolin and rifampin.
Duhon B; Dallas S; Velasquez ST; Hand E
Am J Health Syst Pharm; 2015 Jul; 72(13):1114-8. PubMed ID: 26092962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
